{"entity":{"type":"insider","cik":"0001491874","url":"/insider/0001491874","json_url":"/insider/0001491874.json","name":"Parker Geoffrey M.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":88,"n_filings":53,"first":"2011-05-11","last":"2026-02-04","span_basis":"filed_date"},"name_variants":[{"name":"Parker Geoffrey M.","source":"filing","n_filings":53,"first_seen":"2011-05-11","last_seen":"2026-02-04"}],"transactions":[{"id":6061109,"accession":"0001737287-26-000007","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001737287-26-000007","line_url":"/filing/0001737287-26-000007#line-1","is_derivative":false,"issuer_cik":"0001491874","issuer_name":"Allogene Therapeutics, Inc.","issuer_ticker":"ALLO","issuer_name_source":null,"issuer_url":"/issuer/0001491874","owner_cik":"0001491874","owner_name":"Parker Geoffrey M.","owner_display_name":"Parker Geoffrey M.","owner_url":"/insider/0001491874","role":"Officer (CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24001.0,"shares_display":"24,001","price_per_share":1.76,"price_display":"1.76","price_state":"stated","total_value":42241.76,"total_display":"42,241.76","total_whole":"42,242","shares_owned_after":1252795.0,"shares_owned_after_display":"1,252,795","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-02","filed_date":"2026-02-04","scope":"insider"},{"id":5138346,"accession":"0001491874-25-000007","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001491874-25-000007","line_url":"/filing/0001491874-25-000007#line-1","is_derivative":false,"issuer_cik":"0001491874","issuer_name":"PERRIGO Co plc","issuer_ticker":"PRGO","issuer_name_source":null,"issuer_url":"/issuer/0001491874","owner_cik":"0001491874","owner_name":"Parker Geoffrey M.","owner_display_name":"Parker Geoffrey M.","owner_url":"/insider/0001491874","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7500.0,"shares_display":"7,500","price_per_share":14.18,"price_display":"14.18","price_state":"stated","total_value":106350.0,"total_display":"106,350.00","total_whole":"106,350","shares_owned_after":17375.0,"shares_owned_after_display":"17,375","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-11-12","filed_date":"2025-11-14","scope":"insider"},{"id":4053187,"accession":"0001737287-25-000091","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001737287-25-000091","line_url":"/filing/0001737287-25-000091#line-1","is_derivative":false,"issuer_cik":"0001491874","issuer_name":"Allogene Therapeutics, Inc.","issuer_ticker":"ALLO","issuer_name_source":null,"issuer_url":"/issuer/0001491874","owner_cik":"0001491874","owner_name":"Parker Geoffrey M.","owner_display_name":"Parker Geoffrey M.","owner_url":"/insider/0001491874","role":"Officer (CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":36744.0,"shares_display":"36,744","price_per_share":1.2565,"price_display":"1.26","price_state":"stated","total_value":46168.836,"total_display":"46,168.84","total_whole":"46,169","shares_owned_after":1276796.0,"shares_owned_after_display":"1,276,796","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-21","filed_date":"2025-10-23","scope":"insider"},{"id":9292654,"accession":"0001585364-25-000130","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001585364-25-000130","line_url":"/filing/0001585364-25-000130#line-1","is_derivative":false,"issuer_cik":"0001491874","issuer_name":"PERRIGO Co plc","issuer_ticker":"PRGO","issuer_name_source":null,"issuer_url":"/issuer/0001491874","owner_cik":"0001491874","owner_name":"Parker Geoffrey M.","owner_display_name":"Parker Geoffrey M.","owner_url":"/insider/0001491874","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4375.0,"shares_display":"4,375","price_per_share":22.9708,"price_display":"22.97","price_state":"stated","total_value":100497.25,"total_display":"100,497.25","total_whole":"100,497","shares_owned_after":9875.0,"shares_owned_after_display":"9,875","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-08-18","filed_date":"2025-08-20","scope":"insider"},{"id":4866662,"accession":"0001585364-25-000128","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001585364-25-000128","line_url":"/filing/0001585364-25-000128#line-1","is_derivative":false,"issuer_cik":"0001491874","issuer_name":"PERRIGO Co plc","issuer_ticker":"PRGO","issuer_name_source":null,"issuer_url":"/issuer/0001491874","owner_cik":"0001491874","owner_name":"Parker Geoffrey M.","owner_display_name":"Parker Geoffrey M.","owner_url":"/insider/0001491874","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4375.0,"shares_display":"4,375","price_per_share":22.9708,"price_display":"22.97","price_state":"stated","total_value":100497.25,"total_display":"100,497.25","total_whole":"100,497","shares_owned_after":33287.0,"shares_owned_after_display":"33,287","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-18","filed_date":"2025-08-19","scope":"insider"},{"id":4822696,"accession":"0001585364-25-000058","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001585364-25-000058","line_url":"/filing/0001585364-25-000058#line-1","is_derivative":false,"issuer_cik":"0001491874","issuer_name":"PERRIGO Co plc","issuer_ticker":"PRGO","issuer_name_source":null,"issuer_url":"/issuer/0001491874","owner_cik":"0001491874","owner_name":"Parker Geoffrey M.","owner_display_name":"Parker Geoffrey M.","owner_url":"/insider/0001491874","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3500.0,"shares_display":"3,500","price_per_share":27.1,"price_display":"27.10","price_state":"stated","total_value":94850.0,"total_display":"94,850.00","total_whole":"94,850","shares_owned_after":23762.0,"shares_owned_after_display":"23,762","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-12","filed_date":"2025-05-14","scope":"insider"},{"id":4076178,"accession":"0001737287-25-000019","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001737287-25-000019","line_url":"/filing/0001737287-25-000019#line-1","is_derivative":false,"issuer_cik":"0001491874","issuer_name":"Allogene Therapeutics, Inc.","issuer_ticker":"ALLO","issuer_name_source":null,"issuer_url":"/issuer/0001491874","owner_cik":"0001491874","owner_name":"Parker Geoffrey M.","owner_display_name":"Parker Geoffrey M.","owner_url":"/insider/0001491874","role":"Officer (CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4361.0,"shares_display":"4,361","price_per_share":1.73,"price_display":"1.73","price_state":"stated","total_value":7544.53,"total_display":"7,544.53","total_whole":"7,545","shares_owned_after":1301540.0,"shares_owned_after_display":"1,301,540","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-03","filed_date":"2025-02-05","scope":"insider"},{"id":2403695,"accession":"0001593968-24-000449","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001593968-24-000449","line_url":"/filing/0001593968-24-000449#line-1","is_derivative":false,"issuer_cik":"0001491874","issuer_name":"Allogene Therapeutics, Inc.","issuer_ticker":"ALLO","issuer_name_source":null,"issuer_url":"/issuer/0001491874","owner_cik":"0001491874","owner_name":"Parker Geoffrey M.","owner_display_name":"Parker Geoffrey M.","owner_url":"/insider/0001491874","role":"Officer (CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":190.0,"shares_display":"190","price_per_share":3.595,"price_display":"3.60","price_state":"stated","total_value":683.05,"total_display":"683.05","total_whole":"683","shares_owned_after":819590.0,"shares_owned_after_display":"819,590","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-30","filed_date":"2024-03-06","scope":"insider"},{"id":8518416,"accession":"0000950170-23-035679","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-23-035679","line_url":"/filing/0000950170-23-035679#line-1","is_derivative":false,"issuer_cik":"0001491874","issuer_name":"Better Therapeutics, Inc.","issuer_ticker":"BTTX","issuer_name_source":null,"issuer_url":"/issuer/0001491874","owner_cik":"0001491874","owner_name":"Parker Geoffrey M.","owner_display_name":"Parker Geoffrey M.","owner_url":"/insider/0001491874","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":685025.0,"shares_display":"685,025","price_per_share":0.7299,"price_display":"0.73","price_state":"stated","total_value":499999.7475,"total_display":"499,999.75","total_whole":"500,000","shares_owned_after":1028055.0,"shares_owned_after_display":"1,028,055","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-27","filed_date":"2023-07-31","scope":"insider"},{"id":8635316,"accession":"0001585364-23-000106","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001585364-23-000106","line_url":"/filing/0001585364-23-000106#line-1","is_derivative":false,"issuer_cik":"0001491874","issuer_name":"PERRIGO Co plc","issuer_ticker":"PRGO","issuer_name_source":null,"issuer_url":"/issuer/0001491874","owner_cik":"0001491874","owner_name":"Parker Geoffrey M.","owner_display_name":"Parker Geoffrey M.","owner_url":"/insider/0001491874","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":33.0637,"price_display":"33.06","price_state":"stated","total_value":330637.0,"total_display":"330,637.00","total_whole":"330,637","shares_owned_after":25879.0,"shares_owned_after_display":"25,879","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-06-13","filed_date":"2023-06-14","scope":"insider"},{"id":8213404,"accession":"0000899243-23-011188","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-23-011188","line_url":"/filing/0000899243-23-011188#line-1","is_derivative":false,"issuer_cik":"0001491874","issuer_name":"Better Therapeutics, Inc.","issuer_ticker":"BTTX","issuer_name_source":null,"issuer_url":"/issuer/0001491874","owner_cik":"0001491874","owner_name":"Parker Geoffrey M.","owner_display_name":"Parker Geoffrey M.","owner_url":"/insider/0001491874","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":303030.0,"shares_display":"303,030","price_per_share":0.825,"price_display":"0.82","price_state":"stated","total_value":249999.75,"total_display":"249,999.75","total_whole":"250,000","shares_owned_after":343030.0,"shares_owned_after_display":"343,030","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-10","filed_date":"2023-04-12","scope":"insider"},{"id":7909049,"accession":"0001585364-23-000008","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001585364-23-000008","line_url":"/filing/0001585364-23-000008#line-1","is_derivative":false,"issuer_cik":"0001491874","issuer_name":"PERRIGO Co plc","issuer_ticker":"PRGO","issuer_name_source":null,"issuer_url":"/issuer/0001491874","owner_cik":"0001491874","owner_name":"Parker Geoffrey M.","owner_display_name":"Parker Geoffrey M.","owner_url":"/insider/0001491874","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":38.054,"price_display":"38.05","price_state":"stated","total_value":190270.0,"total_display":"190,270.00","total_whole":"190,270","shares_owned_after":15879.0,"shares_owned_after_display":"15,879","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-03-06","filed_date":"2023-03-07","scope":"insider"},{"id":6767577,"accession":"0000899243-22-022382","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-022382","line_url":"/filing/0000899243-22-022382#line-1","is_derivative":false,"issuer_cik":"0001491874","issuer_name":"Better Therapeutics, Inc.","issuer_ticker":"BTTX","issuer_name_source":null,"issuer_url":"/issuer/0001491874","owner_cik":"0001491874","owner_name":"Parker Geoffrey M.","owner_display_name":"Parker Geoffrey M.","owner_url":"/insider/0001491874","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":1.4473,"price_display":"1.45","price_state":"stated","total_value":36182.5,"total_display":"36,182.50","total_whole":"36,183","shares_owned_after":40000.0,"shares_owned_after_display":"40,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-13","filed_date":"2022-06-14","scope":"insider"},{"id":6341476,"accession":"0000899243-22-012959","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-012959","line_url":"/filing/0000899243-22-012959#line-1","is_derivative":false,"issuer_cik":"0001491874","issuer_name":"Better Therapeutics, Inc.","issuer_ticker":"BTTX","issuer_name_source":null,"issuer_url":"/issuer/0001491874","owner_cik":"0001491874","owner_name":"Parker Geoffrey M.","owner_display_name":"Parker Geoffrey M.","owner_url":"/insider/0001491874","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":2.1487,"price_display":"2.15","price_state":"stated","total_value":32230.5,"total_display":"32,230.50","total_whole":"32,231","shares_owned_after":15000.0,"shares_owned_after_display":"15,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-29","filed_date":"2022-03-31","scope":"insider"},{"id":4332399,"accession":"0001585364-21-000122","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001585364-21-000122","line_url":"/filing/0001585364-21-000122#line-1","is_derivative":false,"issuer_cik":"0001491874","issuer_name":"PERRIGO Co plc","issuer_ticker":"PRGO","issuer_name_source":null,"issuer_url":"/issuer/0001491874","owner_cik":"0001491874","owner_name":"Parker Geoffrey M.","owner_display_name":"Parker Geoffrey M.","owner_url":"/insider/0001491874","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":36.854,"price_display":"36.85","price_state":"stated","total_value":184270.0,"total_display":"184,270.00","total_whole":"184,270","shares_owned_after":10879.0,"shares_owned_after_display":"10,879","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-12-16","filed_date":"2021-12-17","scope":"insider"},{"id":4164569,"accession":"0000899243-21-048609","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-048609","line_url":"/filing/0000899243-21-048609#line-1","is_derivative":false,"issuer_cik":"0001491874","issuer_name":"Better Therapeutics, Inc.","issuer_ticker":"BTTX","issuer_name_source":null,"issuer_url":"/issuer/0001491874","owner_cik":"0001491874","owner_name":"Parker Geoffrey M.","owner_display_name":"Parker Geoffrey M.","owner_url":"/insider/0001491874","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":4.94,"price_display":"4.94","price_state":"stated","total_value":98800.0,"total_display":"98,800.00","total_whole":"98,800","shares_owned_after":53333.0,"shares_owned_after_display":"53,333","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-12-14","filed_date":"2021-12-16","scope":"insider"},{"id":4530365,"accession":"0001585364-21-000041","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001585364-21-000041","line_url":"/filing/0001585364-21-000041#line-1","is_derivative":false,"issuer_cik":"0001491874","issuer_name":"PERRIGO Co plc","issuer_ticker":"PRGO","issuer_name_source":null,"issuer_url":"/issuer/0001491874","owner_cik":"0001491874","owner_name":"Parker Geoffrey M.","owner_display_name":"Parker Geoffrey M.","owner_url":"/insider/0001491874","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":41.2871,"price_display":"41.29","price_state":"stated","total_value":103217.75,"total_display":"103,217.75","total_whole":"103,218","shares_owned_after":2650.0,"shares_owned_after_display":"2,650","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-03-17","filed_date":"2021-03-18","scope":"insider"},{"id":5146635,"accession":"0001209191-21-018788","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-018788","line_url":"/filing/0001209191-21-018788","is_derivative":false,"issuer_cik":"0001340652","issuer_name":"ChemoCentryx, Inc.","issuer_ticker":"CCXI","issuer_name_source":null,"issuer_url":"/issuer/0001340652","owner_cik":"0001491874","owner_name":"Parker Geoffrey M.","owner_display_name":"Parker Geoffrey M.","owner_url":"/insider/0001491874","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":56.3822657,"price_display":"56.38","price_state":"stated","total_value":1691467.971,"total_display":"1,691,467.97","total_whole":"1,691,468","shares_owned_after":26020.0,"shares_owned_after_display":"26,020","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-03-05","filed_date":"2021-03-08","scope":"insider","n_lines":2},{"id":5146624,"accession":"0001209191-21-018788","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-018788","line_url":"/filing/0001209191-21-018788#line-1","is_derivative":false,"issuer_cik":"0001340652","issuer_name":"ChemoCentryx, Inc.","issuer_ticker":"CCXI","issuer_name_source":null,"issuer_url":"/issuer/0001340652","owner_cik":"0001491874","owner_name":"Parker Geoffrey M.","owner_display_name":"Parker Geoffrey M.","owner_url":"/insider/0001491874","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1910.0,"shares_display":"1,910","price_per_share":60.1992,"price_display":"60.20","price_state":"stated","total_value":114980.472,"total_display":"114,980.47","total_whole":"114,980","shares_owned_after":42690.0,"shares_owned_after_display":"42,690","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-03-04","filed_date":"2021-03-08","scope":"insider"},{"id":3265615,"accession":"0001595585-20-000153","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001595585-20-000153","line_url":"/filing/0001595585-20-000153#line-1","is_derivative":false,"issuer_cik":"0001491874","issuer_name":"Tricida, Inc.","issuer_ticker":"TCDA","issuer_name_source":null,"issuer_url":"/issuer/0001491874","owner_cik":"0001491874","owner_name":"Parker Geoffrey M.","owner_display_name":"Parker Geoffrey M.","owner_url":"/insider/0001491874","role":"Officer (CFO and EVP)","role_mark":"O","role_mark_label":"Officer (CFO and EVP)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and EVP","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":6.78,"price_display":"6.78","price_state":"stated","total_value":101700.0,"total_display":"101,700.00","total_whole":"101,700","shares_owned_after":40000.0,"shares_owned_after_display":"40,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-12-10","filed_date":"2020-12-10","scope":"insider"},{"id":2081099,"accession":"0001595585-20-000069","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001595585-20-000069","line_url":"/filing/0001595585-20-000069","is_derivative":false,"issuer_cik":"0001491874","issuer_name":"Tricida, Inc.","issuer_ticker":"TCDA","issuer_name_source":null,"issuer_url":"/issuer/0001491874","owner_cik":"0001491874","owner_name":"Parker Geoffrey M.","owner_display_name":"Parker Geoffrey M.","owner_url":"/insider/0001491874","role":"Officer (Chief Fin. Officer and EVP)","role_mark":"O","role_mark_label":"Officer (Chief Fin. Officer and EVP)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Fin. Officer and EVP","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2742.0,"shares_display":"2,742","price_per_share":30.91393508388038,"price_display":"30.91","price_state":"stated","total_value":84766.01,"total_display":"84,766.01","total_whole":"84,766","shares_owned_after":95000.0,"shares_owned_after_display":"95,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-05-12","filed_date":"2020-05-12","scope":"insider","n_lines":2},{"id":2081096,"accession":"0001595585-20-000069","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001595585-20-000069","line_url":"/filing/0001595585-20-000069","is_derivative":false,"issuer_cik":"0001491874","issuer_name":"Tricida, Inc.","issuer_ticker":"TCDA","issuer_name_source":null,"issuer_url":"/issuer/0001491874","owner_cik":"0001491874","owner_name":"Parker Geoffrey M.","owner_display_name":"Parker Geoffrey M.","owner_url":"/insider/0001491874","role":"Officer (Chief Fin. Officer and EVP)","role_mark":"O","role_mark_label":"Officer (Chief Fin. Officer and EVP)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Fin. Officer and EVP","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":32258.0,"shares_display":"32,258","price_per_share":30.021618203236407,"price_display":"30.02","price_state":"stated","total_value":968437.36,"total_display":"968,437.36","total_whole":"968,437","shares_owned_after":92258.0,"shares_owned_after_display":"92,258","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-05-11","filed_date":"2020-05-12","scope":"insider","n_lines":2},{"id":2644641,"accession":"0001209191-20-021176","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-20-021176","line_url":"/filing/0001209191-20-021176","is_derivative":false,"issuer_cik":"0001340652","issuer_name":"ChemoCentryx, Inc.","issuer_ticker":"CCXI","issuer_name_source":null,"issuer_url":"/issuer/0001340652","owner_cik":"0001491874","owner_name":"Parker Geoffrey M.","owner_display_name":"Parker Geoffrey M.","owner_url":"/insider/0001491874","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":36.70163212666667,"price_display":"36.70","price_state":"stated","total_value":1101048.9638,"total_display":"1,101,048.96","total_whole":"1,101,049","shares_owned_after":50460.0,"shares_owned_after_display":"50,460","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-03-23","filed_date":"2020-03-25","scope":"insider","n_lines":5},{"id":3162649,"accession":"0001595585-20-000038","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001595585-20-000038","line_url":"/filing/0001595585-20-000038#line-1","is_derivative":false,"issuer_cik":"0001491874","issuer_name":"Tricida, Inc.","issuer_ticker":"TCDA","issuer_name_source":null,"issuer_url":"/issuer/0001491874","owner_cik":"0001491874","owner_name":"Parker Geoffrey M.","owner_display_name":"Parker Geoffrey M.","owner_url":"/insider/0001491874","role":"Officer (Chief Fin. Officer and EVP)","role_mark":"O","role_mark_label":"Officer (Chief Fin. Officer and EVP)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Fin. Officer and EVP","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":29.46,"price_display":"29.46","price_state":"stated","total_value":147300.0,"total_display":"147,300.00","total_whole":"147,300","shares_owned_after":55000.0,"shares_owned_after_display":"55,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-03-10","filed_date":"2020-03-11","scope":"insider"},{"id":7849617,"accession":"0001595585-19-000262","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001595585-19-000262","line_url":"/filing/0001595585-19-000262#line-2","is_derivative":false,"issuer_cik":"0001491874","issuer_name":"Tricida, Inc.","issuer_ticker":"TCDA","issuer_name_source":null,"issuer_url":"/issuer/0001491874","owner_cik":"0001491874","owner_name":"Parker Geoffrey M.","owner_display_name":"Parker Geoffrey M.","owner_url":"/insider/0001491874","role":"Officer (Chief Fin. Officer and Sr. VP)","role_mark":"O","role_mark_label":"Officer (Chief Fin. Officer and Sr. VP)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Fin. Officer and Sr. VP","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":945.0,"shares_display":"945","price_per_share":34.72,"price_display":"34.72","price_state":"stated","total_value":32810.4,"total_display":"32,810.40","total_whole":"32,810","shares_owned_after":50000.0,"shares_owned_after_display":"50,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-11-19","filed_date":"2019-11-19","scope":"insider"},{"id":7849614,"accession":"0001595585-19-000262","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001595585-19-000262","line_url":"/filing/0001595585-19-000262#line-1","is_derivative":false,"issuer_cik":"0001491874","issuer_name":"Tricida, Inc.","issuer_ticker":"TCDA","issuer_name_source":null,"issuer_url":"/issuer/0001491874","owner_cik":"0001491874","owner_name":"Parker Geoffrey M.","owner_display_name":"Parker Geoffrey M.","owner_url":"/insider/0001491874","role":"Officer (Chief Fin. Officer and Sr. VP)","role_mark":"O","role_mark_label":"Officer (Chief Fin. Officer and Sr. VP)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Fin. Officer and Sr. VP","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":19055.0,"shares_display":"19,055","price_per_share":34.28,"price_display":"34.28","price_state":"stated","total_value":653205.4,"total_display":"653,205.40","total_whole":"653,205","shares_owned_after":49055.0,"shares_owned_after_display":"49,055","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-11-18","filed_date":"2019-11-19","scope":"insider"},{"id":7869337,"accession":"0001595585-19-000170","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001595585-19-000170","line_url":"/filing/0001595585-19-000170","is_derivative":false,"issuer_cik":"0001491874","issuer_name":"Tricida, Inc.","issuer_ticker":"TCDA","issuer_name_source":null,"issuer_url":"/issuer/0001491874","owner_cik":"0001491874","owner_name":"Parker Geoffrey M.","owner_display_name":"Parker Geoffrey M.","owner_url":"/insider/0001491874","role":"Officer (Chief Fin. Officer and Sr. VP)","role_mark":"O","role_mark_label":"Officer (Chief Fin. Officer and Sr. VP)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Fin. Officer and Sr. VP","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":11947.0,"shares_display":"11,947","price_per_share":33.17168828994727,"price_display":"33.17","price_state":"stated","total_value":396302.16,"total_display":"396,302.16","total_whole":"396,302","shares_owned_after":25469.0,"shares_owned_after_display":"25,469","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-08-13","filed_date":"2019-08-14","scope":"insider","n_lines":2},{"id":7869332,"accession":"0001595585-19-000170","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001595585-19-000170","line_url":"/filing/0001595585-19-000170","is_derivative":false,"issuer_cik":"0001491874","issuer_name":"Tricida, Inc.","issuer_ticker":"TCDA","issuer_name_source":null,"issuer_url":"/issuer/0001491874","owner_cik":"0001491874","owner_name":"Parker Geoffrey M.","owner_display_name":"Parker Geoffrey M.","owner_url":"/insider/0001491874","role":"Officer (Chief Fin. Officer and Sr. VP)","role_mark":"O","role_mark_label":"Officer (Chief Fin. Officer and Sr. VP)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Fin. Officer and Sr. VP","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":18053.0,"shares_display":"18,053","price_per_share":31.771326649310364,"price_display":"31.77","price_state":"stated","total_value":573567.76,"total_display":"573,567.76","total_whole":"573,568","shares_owned_after":15476.0,"shares_owned_after_display":"15,476","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-08-12","filed_date":"2019-08-14","scope":"insider","n_lines":2},{"id":8514748,"accession":"0001209191-19-034054","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-034054","line_url":"/filing/0001209191-19-034054#line-2","is_derivative":false,"issuer_cik":"0001340652","issuer_name":"ChemoCentryx, Inc.","issuer_ticker":"CCXI","issuer_name_source":null,"issuer_url":"/issuer/0001340652","owner_cik":"0001491874","owner_name":"Parker Geoffrey M.","owner_display_name":"Parker Geoffrey M.","owner_url":"/insider/0001491874","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12815.0,"shares_display":"12,815","price_per_share":12.002,"price_display":"12.00","price_state":"stated","total_value":153805.63,"total_display":"153,805.63","total_whole":"153,806","shares_owned_after":72199.0,"shares_owned_after_display":"72,199","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-30","filed_date":"2019-06-03","scope":"insider"},{"id":6450042,"accession":"0001595585-18-000020","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001595585-18-000020","line_url":"/filing/0001595585-18-000020#line-1","is_derivative":false,"issuer_cik":"0001491874","issuer_name":"Tricida, Inc.","issuer_ticker":"TCDA","issuer_name_source":null,"issuer_url":"/issuer/0001491874","owner_cik":"0001491874","owner_name":"Parker Geoffrey M.","owner_display_name":"Parker Geoffrey M.","owner_url":"/insider/0001491874","role":"Officer (Chief Fin. Officer and Sr. VP)","role_mark":"O","role_mark_label":"Officer (Chief Fin. Officer and Sr. VP)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Fin. Officer and Sr. VP","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":29.72,"price_display":"29.72","price_state":"stated","total_value":148600.0,"total_display":"148,600.00","total_whole":"148,600","shares_owned_after":65000.0,"shares_owned_after_display":"65,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-13","filed_date":"2018-11-13","scope":"insider"},{"id":6167547,"accession":"0001585364-18-000097","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001585364-18-000097","line_url":"/filing/0001585364-18-000097#line-1","is_derivative":false,"issuer_cik":"0001491874","issuer_name":"PERRIGO Co plc","issuer_ticker":"PRGO","issuer_name_source":null,"issuer_url":"/issuer/0001491874","owner_cik":"0001491874","owner_name":"Parker Geoffrey M.","owner_display_name":"Parker Geoffrey M.","owner_url":"/insider/0001491874","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":65.3527,"price_display":"65.35","price_state":"stated","total_value":196058.1,"total_display":"196,058.10","total_whole":"196,058","shares_owned_after":5500.0,"shares_owned_after_display":"5,500","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-11-12","filed_date":"2018-11-13","scope":"insider"},{"id":6192288,"accession":"0001140361-18-031039","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-18-031039","line_url":"/filing/0001140361-18-031039#line-1","is_derivative":false,"issuer_cik":"0001491874","issuer_name":"Tricida, Inc.","issuer_ticker":"TCDA","issuer_name_source":null,"issuer_url":"/issuer/0001491874","owner_cik":"0001491874","owner_name":"Parker Geoffrey M.","owner_display_name":"Parker Geoffrey M.","owner_url":"/insider/0001491874","role":"Officer (Chief Fin. Officer and Sr. VP)","role_mark":"O","role_mark_label":"Officer (Chief Fin. Officer and Sr. VP)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Fin. Officer and Sr. VP","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":60000.0,"shares_display":"60,000","price_per_share":19.0,"price_display":"19.00","price_state":"stated","total_value":1140000.0,"total_display":"1,140,000.00","total_whole":"1,140,000","shares_owned_after":60000.0,"shares_owned_after_display":"60,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-02","filed_date":"2018-07-02","scope":"insider"},{"id":9242270,"accession":"0001179110-16-033153","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-16-033153","line_url":"/filing/0001179110-16-033153#line-2","is_derivative":false,"issuer_cik":"0001061027","issuer_name":"SUNESIS PHARMACEUTICALS INC","issuer_ticker":"SNSS","issuer_name_source":null,"issuer_url":"/issuer/0001061027","owner_cik":"0001491874","owner_name":"Parker Geoffrey M.","owner_display_name":"Parker Geoffrey M.","owner_url":"/insider/0001491874","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":594.0,"shares_display":"594","price_per_share":3.9018,"price_display":"3.90","price_state":"stated","total_value":2317.6692,"total_display":"2,317.67","total_whole":"2,318","shares_owned_after":14074.0,"shares_owned_after_display":"14,074","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-12-09","filed_date":"2016-12-16","scope":"insider"},{"id":3252548,"accession":"0001179110-16-032838","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-16-032838","line_url":"/filing/0001179110-16-032838#line-2","is_derivative":false,"issuer_cik":"0001061027","issuer_name":"SUNESIS PHARMACEUTICALS INC","issuer_ticker":"SNSS","issuer_name_source":null,"issuer_url":"/issuer/0001061027","owner_cik":"0001491874","owner_name":"Parker Geoffrey M.","owner_display_name":"Parker Geoffrey M.","owner_url":"/insider/0001491874","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":594.0,"shares_display":"594","price_per_share":3.9018,"price_display":"3.90","price_state":"stated","total_value":2317.6692,"total_display":"2,317.67","total_whole":"2,318","shares_owned_after":65745.0,"shares_owned_after_display":"65,745","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-12-09","filed_date":"2016-12-12","scope":"insider"},{"id":9242271,"accession":"0001179110-16-033153","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-16-033153","line_url":"/filing/0001179110-16-033153#line-1","is_derivative":false,"issuer_cik":"0001061027","issuer_name":"SUNESIS PHARMACEUTICALS INC","issuer_ticker":"SNSS","issuer_name_source":null,"issuer_url":"/issuer/0001061027","owner_cik":"0001491874","owner_name":"Parker Geoffrey M.","owner_display_name":"Parker Geoffrey M.","owner_url":"/insider/0001491874","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3146.0,"shares_display":"3,146","price_per_share":3.865,"price_display":"3.86","price_state":"stated","total_value":12159.29,"total_display":"12,159.29","total_whole":"12,159","shares_owned_after":13480.0,"shares_owned_after_display":"13,480","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-12-08","filed_date":"2016-12-16","scope":"insider"},{"id":3252543,"accession":"0001179110-16-032838","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-16-032838","line_url":"/filing/0001179110-16-032838#line-1","is_derivative":false,"issuer_cik":"0001061027","issuer_name":"SUNESIS PHARMACEUTICALS INC","issuer_ticker":"SNSS","issuer_name_source":null,"issuer_url":"/issuer/0001061027","owner_cik":"0001491874","owner_name":"Parker Geoffrey M.","owner_display_name":"Parker Geoffrey M.","owner_url":"/insider/0001491874","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3146.0,"shares_display":"3,146","price_per_share":3.865,"price_display":"3.86","price_state":"stated","total_value":12159.29,"total_display":"12,159.29","total_whole":"12,159","shares_owned_after":65151.0,"shares_owned_after_display":"65,151","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-12-08","filed_date":"2016-12-12","scope":"insider"},{"id":2463137,"accession":"0001585364-16-000440","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001585364-16-000440","line_url":"/filing/0001585364-16-000440#line-1","is_derivative":false,"issuer_cik":"0001491874","issuer_name":"PERRIGO Co plc","issuer_ticker":"PRGO","issuer_name_source":null,"issuer_url":"/issuer/0001491874","owner_cik":"0001491874","owner_name":"Parker Geoffrey M.","owner_display_name":"Parker Geoffrey M.","owner_url":"/insider/0001491874","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":88.75,"price_display":"88.75","price_state":"stated","total_value":221875.0,"total_display":"221,875.00","total_whole":"221,875","shares_owned_after":2500.0,"shares_owned_after_display":"2,500","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-11-21","filed_date":"2016-11-21","scope":"insider"},{"id":2540928,"accession":"0001179110-16-025648","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-16-025648","line_url":"/filing/0001179110-16-025648#line-1","is_derivative":false,"issuer_cik":"0001061027","issuer_name":"SUNESIS PHARMACEUTICALS INC","issuer_ticker":"SNSS","issuer_name_source":null,"issuer_url":"/issuer/0001061027","owner_cik":"0001491874","owner_name":"Parker Geoffrey M.","owner_display_name":"Parker Geoffrey M.","owner_url":"/insider/0001491874","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9500.0,"shares_display":"9,500","price_per_share":0.4689,"price_display":"0.47","price_state":"stated","total_value":4454.55,"total_display":"4,454.55","total_whole":"4,455","shares_owned_after":62005.0,"shares_owned_after_display":"62,005","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-26","filed_date":"2016-05-27","scope":"insider"},{"id":2768349,"accession":"0001179110-16-025586","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-16-025586","line_url":"/filing/0001179110-16-025586#line-2","is_derivative":false,"issuer_cik":"0001061027","issuer_name":"SUNESIS PHARMACEUTICALS INC","issuer_ticker":"SNSS","issuer_name_source":null,"issuer_url":"/issuer/0001061027","owner_cik":"0001491874","owner_name":"Parker Geoffrey M.","owner_display_name":"Parker Geoffrey M.","owner_url":"/insider/0001491874","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":22505.0,"shares_display":"22,505","price_per_share":0.4858,"price_display":"0.49","price_state":"stated","total_value":10932.929,"total_display":"10,932.93","total_whole":"10,933","shares_owned_after":52505.0,"shares_owned_after_display":"52,505","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-25","filed_date":"2016-05-26","scope":"insider"},{"id":2768341,"accession":"0001179110-16-025586","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-16-025586","line_url":"/filing/0001179110-16-025586#line-1","is_derivative":false,"issuer_cik":"0001061027","issuer_name":"SUNESIS PHARMACEUTICALS INC","issuer_ticker":"SNSS","issuer_name_source":null,"issuer_url":"/issuer/0001061027","owner_cik":"0001491874","owner_name":"Parker Geoffrey M.","owner_display_name":"Parker Geoffrey M.","owner_url":"/insider/0001491874","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":30000.0,"shares_display":"30,000","price_per_share":0.4627,"price_display":"0.46","price_state":"stated","total_value":13881.0,"total_display":"13,881.00","total_whole":"13,881","shares_owned_after":30000.0,"shares_owned_after_display":"30,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-24","filed_date":"2016-05-26","scope":"insider"},{"id":3173473,"accession":"0001209191-16-119901","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-119901","line_url":"/filing/0001209191-16-119901#line-1","is_derivative":false,"issuer_cik":"0001340652","issuer_name":"ChemoCentryx, Inc.","issuer_ticker":"CCXI","issuer_name_source":null,"issuer_url":"/issuer/0001340652","owner_cik":"0001491874","owner_name":"Parker Geoffrey M.","owner_display_name":"Parker Geoffrey M.","owner_url":"/insider/0001491874","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":40000.0,"shares_display":"40,000","price_per_share":4.0347,"price_display":"4.03","price_state":"stated","total_value":161388.0,"total_display":"161,388.00","total_whole":"161,388","shares_owned_after":99600.0,"shares_owned_after_display":"99,600","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-05-13","filed_date":"2016-05-13","scope":"insider"}],"collapsed":true,"next_cursor":"2016-05-13|3173473","ledger_fault":false,"count":{"value":88,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":75,"open_market":true},{"code":"S","label":"Open-market sale","n":13,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":88},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001737287","name":"Allogene Therapeutics, Inc.","url":"/issuer/0001737287","role":"Officer (CHIEF FINANCIAL OFFICER)","n_filings":4,"first_seen":"2024-03-06","last_seen":"2026-02-04"},{"type":"issuer","type_label":"ISSUER","cik":"0001585364","name":"PERRIGO Co plc","url":"/issuer/0001585364","role":"Director","n_filings":10,"first_seen":"2016-11-21","last_seen":"2025-11-14"},{"type":"issuer","type_label":"ISSUER","cik":"0001832415","name":"Better Therapeutics, Inc.","url":"/issuer/0001832415","role":"Director","n_filings":5,"first_seen":"2021-12-16","last_seen":"2023-07-31"},{"type":"issuer","type_label":"ISSUER","cik":"0001340652","name":"ChemoCentryx, Inc.","url":"/issuer/0001340652","role":"Director","n_filings":9,"first_seen":"2012-02-13","last_seen":"2021-03-08"},{"type":"issuer","type_label":"ISSUER","cik":"0001595585","name":"Tricida, Inc.","url":"/issuer/0001595585","role":"Officer (CFO and EVP)","n_filings":7,"first_seen":"2018-07-02","last_seen":"2020-12-10"},{"type":"issuer","type_label":"ISSUER","cik":"0001061027","name":"SUNESIS PHARMACEUTICALS INC","url":"/issuer/0001061027","role":"Director","n_filings":4,"first_seen":"2016-05-26","last_seen":"2016-12-16"},{"type":"issuer","type_label":"ISSUER","cik":"0001411158","name":"Anacor Pharmaceuticals, Inc.","url":"/issuer/0001411158","role":"Officer (Executive Vice President & CFO)","n_filings":14,"first_seen":"2011-05-11","last_seen":"2015-03-23"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001491874","retrieved_at":"2026-08-25T18:35:33+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}